Functionalizing liposomes could pave the way to personalised medicine
Researchers have shown a method to functionalize liposomes for specific targeting, potentially paving the way for personalised medicine...
List view / Grid view
News
Integrated lab-on-a-chip uses smartphone to detect multiple pathogens
Researchers have developed a platform to diagnose infectious diseases at the point-of-care, using a smartphone as the detection instrument...
CPhI Annual Report reveals slow and discouraging trends in current drug pipelines
CPhI Worldwide report states the current drugs pipeline is discouraging and slowing simple manufacturing innovations...
FDA approves Yescarta to treat adults with B-cell lymphoma
The FDA has approved Yescarta, a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma...
FDA accepts regulatory submission for Lynparza in metastatic breast cancer
Lynparza has the potential to offer a new treatment option for patients with metastatic breast cancer...
Revolade shows long-term disease control for immune thrombocytopenia
Novartis has announced long-term study results supporting the positive safety and efficacy of Revolade in adults with chronic/persistent immune thrombocytopenia...
Arsenic identified as a potential treatment for brain cancer
Arsenic trioxide could extend the survival of glioblastoma patients by three to four times the historic median...
Oral semaglutide shows promise for type 2 diabetes
Researchers have identified that the drug semaglutide resulted in better glycemic control than placebo for patients with type 2 diabetes...
DOACs used as a alternative to warfarin to treat venous thromboembolism
A study has found that a new group of drugs used to treat patients with serious blood clots are not associated with a higher risk of major bleeding compared with warfarin...
Flu vaccine found to be ineffective in leukaemia patients
Leukaemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals...
Macrophages play critical role in sustained delivery of MD therapy
Inflammatory cells retain drug after it disappears from circulation, improving delivery to regenerating muscle cells...
Janssen announces FDA approval of Stelara for plaque psoriasis
The FDA has approved an expanded indication for Stelara for the treatment of adolescents with moderate plaque psoriasis...
Experimental Ebola vaccines elicit year-long immune response
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year...
Experimental nano-chemo particle to treat bladder cancer
Researchers have developed a way to successfully deliver nano-sized, platinum-based chemotherapy drugs to treat a form of bladder cancer...
NIH launches $215m partnership for cancer immunotherapy strategies
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
